Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on June 5, 2025
A look at how CNH and Nature’s Net Wrap are rolling out a world-first natural solution to plastic pollution
GlobeNewswire
·
June 5, 2025
A look at how CNH and Nature’s Net Wrap are rolling out a world-first natural solution to plastic pollution Basildon, June 5, 2025 The latest installment in our ‘A Sustainable Year’ series spotlights the science behind Canadian bale storage innovator …
Robex Resources commences ASX trading following A$120M IPO
GlobeNewswire
·
June 5, 2025
Highlights: Robex Resources Inc. (ASX:RXR) commenced trading on the Australian Securities Exchange (ASX) at 11am AEST today after completing an Initial Public Offer (IPO) which raised A$120M before costs. Robex is a West African gold producer and developer …
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Huma Deploys Hi Scribe to Automate Clinical Documentation and Billing Using AI
GlobeNewswire
·
June 5, 2025
New York, June 05, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics, the global healthcare AI company, today announced the launch of Hi Scribe, a generative AI clinical documentation tool designed to automate and streamline the creation of clinical notes and …
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Catches Wall Street’s Attention, Offers Sustainable Way to Gain Exposure to Gold
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio @IBN , a …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
GlobeNewswire
·
June 5, 2025
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed follicular lymphoma, and in …
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
GlobeNewswire
·
June 5, 2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its unique broad-based vaccine technology at …
Aventis Energy Announces Intent to Complete NI 43-101 Technical Report on the Corvo Uranium Project
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to announce that it has contracted Axiom Exploration Group Ltd. (“Axiom”) to complete a Technical …
Maxus Mining Announces Acquisition of a Portfolio of High-Grade Antimony & Tungsten Projects
GlobeNewswire
·
June 5, 2025
Highlights: High-Grade Antimony Grab Sample at the Quarry Project – A sample assayed 0.89% g/t Au, 3.8% Cu, 0.34% Zn, 42.5% Pb, and 0.65% g/t Ag and 20% Sb.1 A High-Grade Tungsten Sample at the Lotto Project – A selected grab sample taken in 1980 from a …
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
GlobeNewswire
·
June 5, 2025
BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) …
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
GlobeNewswire
·
June 5, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
GlobeNewswire
·
June 5, 2025
EMA Orphan Drug Designation (ODD) builds on U.S. Food …
MentalMed Group GmbH Launches Range of Mental Training Services for Athletes and High Performers
GlobeNewswire
·
June 5, 2025
Zurich, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- MentalMed Group GmbH (mymentalcoach.ch) is excited to announce the launch of its range of mental training services, including sports mental training and autogenic training, to offer athletes and high …
ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
GlobeNewswire
·
June 5, 2025
VeonGen advances two proprietary, first-in-class gene therapies in the clinic, enabled by its novel vgRNA REVeRT and vgAAV technology platforms Lead program VG801 receives FDA Rare Pediatric Disease Designation and is progressing in a first-in-human Phase …
Onno Plus GmbH Announces Help for Local Companies to Fight Abusive and Fake Google Reviews
GlobeNewswire
·
June 5, 2025
Berlin, Germany, June 05, 2025 (GLOBE NEWSWIRE) -- Onno Plus GmbH (https://onnoplus.de/), a leading reputation management company for small to medium-sized businesses, is excited to announce the launch of its range of services that have been expertly …
Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty
GlobeNewswire
·
June 5, 2025
AMSTERDAM, June 05, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, a leading European pharmaceutical manufacturer, has joined fellow members of Medicines for Europe in signing an open letter addressed to the Prime Ministers and Ministers of Health of all 27 EU …
Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment
GlobeNewswire
·
June 5, 2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: …
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
GlobeNewswire
·
June 5, 2025
BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions, today …
Marex Agrees to Acquire Agrinvest Commodities
GlobeNewswire
·
June 5, 2025
LONDON, June 05, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces that it has agreed to acquire Agrinvest Commodities, a Brazilian agricultural commodities …
Constellium Joins America Makes Project to Advance Use of Aluminum Additive Manufacturing in Defense and Aerospace
GlobeNewswire
·
June 5, 2025
PARIS, June 05, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced the kick off of a new collaborative project with Nikon Advanced Manufacturing (Nikon AM), America Makes, and a team of industry leaders to expand the use of its Aheadd® …